Oral Semaglutide
OASIS 4
Novo Nordisk · Phase 3 · Completed · Enrollment 307
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Oral semaglutide 25 mg | Obesity or overweight | 25 mg | n/r | n/r | n/r |
| Oral semaglutide placebo | Obesity or overweight | n/r | n/r | n/r | n/r |